Drug
Hydronidone clinical trials
- studies test it
- 14
- open now
- 3
- in phase 3
- 4
- first study started
- 2015
Keep track of what changes. Save the hydronidone studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
14 studies that test it; most in 2026 (6)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 3 |
| 2026 | 6 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
- Phase 2
- 3
- Phase 3
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 14 · Other 0
Beijing Continent Pharmaceutical Co, Ltd. (13) · Shanghai Genomics, Inc. (1)
Studies
Open first, then newest update. How each study uses hydronidone is read from its arms, and is right about nine times in ten.
Testing it · 14
- A Trial of Hydroxynidone Capsules in Single-dose Administration for Patients With Renal InsufficiencyRecruitingPhase 1Beijing Continent Pharmaceutical Co, Ltd.NCT07262333Written as Hydronidone capsules
- A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B.Not yet recruitingPhase 3Beijing Continent Pharmaceutical Co, Ltd.NCT07412236Written as Hydronidone (270mg)
- Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver FibrosisRecruitingPhase 3Beijing Continent Pharmaceutical Co, Ltd.NCT05905172Written as Hydronidone capsules
- The Phase Ⅰd Clinical Trial of Hydronidone CapsulesCompletedPhase 1Beijing Continent Pharmaceutical Co, Ltd.NCT07262346Written as Hydronidone capsules
- [¹⁴C] Hydronidone Mass Balance StudyCompletedPhase 1Beijing Continent Pharmaceutical Co, Ltd.NCT07471217Written as [¹⁴C]Hydronidone
- Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy ControlsCompletedPhase 1Beijing Continent Pharmaceutical Co, Ltd.NCT07394309Written as Hydronidone capsules
- A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver CirrhosisCompletedPhase 3Beijing Continent Pharmaceutical Co, Ltd.NCT07343778Written as Hydronidone Capsules
- QTc Assessment in a Single-Dose Study of Hydronidone CapsulesCompletedPhase 1Beijing Continent Pharmaceutical Co, Ltd.NCT07263152Written as Hydronidone
- A Study of Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver FibrosisCompletedPhase 2Beijing Continent Pharmaceutical Co, Ltd.NCT07417553Written as Hydronidone capsules
- A Study to Evaluate the Safety of Hydronidone Capsules in Patients With Liver FibrosisCompletedPhase 2Beijing Continent Pharmaceutical Co, Ltd.NCT07364448Written as Hydronidone capsules
- Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial.CompletedPhase 3Beijing Continent Pharmaceutical Co, Ltd.NCT05115942Written as Hydronidone capsules
- A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic HepatitisCompletedPhase 2Shanghai Genomics, Inc.NCT02499562Written as Hydronidone
- Study on PK of Hydronidone in Patients and Special PopulationCompletedPhase 1Beijing Continent Pharmaceutical Co, Ltd.NCT04123769Written as Hydronidone
- Study on Pharmacokinetics of HydronidoneCompletedPhase 1Beijing Continent Pharmaceutical Co, Ltd.NCT04162821Written as Hydronidone
Codes
What other systems call hydronidone · ClinicalTrials.gg INT000766
- MeSH (NLM) C000621986hydronidoneOne source ClinicalTrials.gov
- Wikidata Q27288328hydronidoneOne source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000621986 | hydronidone | One source ClinicalTrials.gov |
| Wikidata | Q27288328 | hydronidone | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.